MindMed

MindMed is a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be a global leader in the development and delivery of treatments that create new opportunities to improve patient outcomes. We are developing a pipeline of innovative product candidates, both with and without acute perceptual effects, targeting neurotransmitter pathways that play a key role in brain health disorders.